The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia.
about
Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2Expression of the outcome predictor in acute leukemia 1 (OPAL1) gene is not an independent prognostic factor in patients treated according to COALL or St Jude protocolsMitophagy programs: mechanisms and physiological implications of mitochondrial targeting by autophagyThe clinically relevant pharmacogenomic changes in acute myelogenous leukemiaMolecular hallmarks of endogenous chromatin complexes containing master regulators of hematopoiesisGenome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemiaIdentification of a 5-gene signature for clinical and prognostic prediction in gastric cancer patients upon microarray data.Inherited mitochondrial DNA variants can affect complement, inflammation and apoptosis pathways: insights into mitochondrial-nuclear interactions.Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targeting.Bcl2L13 is a ceramide synthase inhibitor in glioblastoma.Identification of common microRNA-mRNA regulatory biomodules in human epithelial cancers.Acute lymphoblastic leukemia cells that survive combination chemotherapy in vivo remain sensitive to allogeneic immune effects.A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity.Prognostic significance of survivin in pediatric acute lymphoblastic leukemia.TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia.ZIC1 overexpression is oncogenic in liposarcoma.Elucidating the identity of resistance mechanisms to prednisolone exposure in acute lymphoblastic leukemia cells through transcriptomic analysis: A computational approach.Methylation of death-associated protein kinase is associated with cetuximab and erlotinib resistance.The Human Bcl-2 Family Member Bcl-rambo Localizes to Mitochondria and Induces Apoptosis and Morphological Aberrations in Drosophila.Rapid engraftment of human ALL in NOD/SCID mice involves deficient apoptosis signalingBiomarkers for the development of cancer vaccines: current status.PEG-asparaginase.Novel targeted drug therapies for the treatment of childhood acute leukemiaImpact of promoter polymorphisms in key regulators of the intrinsic apoptosis pathway on the outcome of childhood acute lymphoblastic leukemiaThe Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic LeukemiasGene and MicroRNA Expression Are Predictive of Tumor Response in Rectal Adenocarcinoma Patients Treated With Preoperative Chemoradiotherapy.The impact of TEL-AML1 (ETV6-RUNX1) expression in precursor B cells and implications for leukaemia using three different genome-wide screening methods.Proteomic analysis of the secretome of porcine alveolar macrophages infected with porcine reproductive and respiratory syndrome virus.Approaches to the discovery of pharmacogenomic markers in oncology: 2000-2010-2020.Glycogen synthase kinase-3β inhibition induces nuclear factor-κB-mediated apoptosis in pediatric acute lymphocyte leukemia cells.Identifying new targets in leukemogenesis using computational approaches.A unique complex translocation involving six different chromosomes in a case of childhood acute lymphoblastic leukemia with the Philadelphia chromosome and adverse prognosis.Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism.Cooperation of ETV6/RUNX1 and BCL2 enhances immunoglobulin production and accelerates glomerulonephritis in transgenic mice.Gene expression pattern contributing to prognostic factors in childhood acute lymphoblastic leukemia.Mitochondrial genome variants in non-remitting ALL of childhood.Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia.Gene expression signatures and ex vivo drug sensitivity profiles in children with acute lymphoblastic leukemia.Identification of key regulators and their controlling mechanism in a combinatorial apoptosis network: a systems biology approach.Genomic and transcriptomic profiles and in vitro resistance to mitoxantrone and idarubicin in pediatric acute leukemias.
P2860
Q24685514-694DC96B-13D9-4943-9363-A7FA7ACF2CDCQ24685883-64A55A69-AD33-4B0D-A4DF-E1256EE3E382Q26776469-2C197422-B4BC-46B5-A63D-1D0E219CA9A1Q27014790-B342960E-3981-494B-AC76-844A441D9CEFQ28586268-045D8FB5-908B-458D-BB6D-1565E61C231EQ28943308-BED615FB-0D14-4110-BA7B-7A0BE6743550Q30659104-B3999DEA-D09A-4EA6-AF57-784B8D151CDFQ33725857-475D1C71-1352-45B7-BE57-9D4390711AFAQ33931890-B41CE16E-EB50-45BC-B7F0-A9CE3175EB29Q34413943-C3DD372A-B912-43E5-9460-1FFC92C58B04Q34577943-17E18309-5A9A-4B18-AD7C-7B03F52D5541Q34634251-4D411F74-4842-49C9-ADB1-2021F36EB541Q34989475-440564B7-0692-4F4C-8653-A3B307C6C9CDQ35008726-337E9EE0-C0B2-4794-A4A7-A0F68C18813BQ35108114-1DB57DE5-E3CD-4ABD-BF4D-0D3F37F0838EQ35699924-A765611B-C235-4A59-92C0-E8013656AF55Q35856573-C6A891B1-CED5-48E3-A500-D6CEB1A3F50EQ35925441-5585CCDA-C072-4672-BE5B-BB83A3B73EE4Q36062514-A4343139-1DEA-4409-A603-2861C4B41AF7Q36211488-1041B985-0533-4DC6-B91C-8B9AC62F1449Q36677261-045DFEC6-1BE7-4FB5-84AC-B7003D227EC4Q36909298-725A01EF-CC49-4215-AE96-20C7DEFDE6F3Q37477482-DFA75C85-C772-4C60-9D62-C40A14637376Q37552035-2847A8A9-537A-4C71-8622-FDE6550773B7Q38439738-12711FFB-24CB-46BE-9544-4E32BB932127Q38441043-FCF18BDC-6579-4907-9307-4CB7922EB719Q39079942-B1437451-AEB5-461C-AF0B-EE0AC394B83CQ40045457-A76361B6-2476-424B-8F84-4855D763AD15Q40364215-1B246DEF-C059-4301-A4AD-91A12E4E7E14Q41167448-87A1212F-F942-4F25-92CE-0DE9E0246365Q41903687-56879E0C-0C14-49F2-828E-31961200774DQ42017612-FD512B59-FCDB-4A5F-A22A-634C3010410CQ42165650-ABB11A6D-1E10-4B49-8889-DCF09FF2A0B0Q42594064-2FAA2C0D-0610-4910-ACC6-797E8CC13A00Q44591810-59C777D9-2EA3-4E14-BFBF-6BDEEA0C30BFQ45244424-83589D08-5DA5-48A9-9F40-7C4D8BDDA718Q47754054-6D3AAD1E-BD0A-43FC-B1A7-1D500536B05DQ50267725-13A59923-DD55-4399-8D38-98C0E1AF6231Q51380778-AC99B6C4-593A-4393-B5D9-DB3233614DB1Q53086558-1A10AAF9-DF17-4AAF-A52B-F1889C44A969
P2860
The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The expression of 70 apoptosis ...... acute lymphoblastic leukemia.
@en
The expression of 70 apoptosis ...... acute lymphoblastic leukemia.
@nl
type
label
The expression of 70 apoptosis ...... acute lymphoblastic leukemia.
@en
The expression of 70 apoptosis ...... acute lymphoblastic leukemia.
@nl
prefLabel
The expression of 70 apoptosis ...... acute lymphoblastic leukemia.
@en
The expression of 70 apoptosis ...... acute lymphoblastic leukemia.
@nl
P2093
P2860
P1433
P1476
The expression of 70 apoptosis ...... acute lymphoblastic leukemia.
@en
P2093
Amy Holleman
Cheng Cheng
Gritta E Janka-Schaub
Karin M Kazemier
Meyling H Cheok
Renée X de Menezes
Ulrich Göbel
Ulrike B Graubner
William E Evans
P2860
P304
P356
10.1182/BLOOD-2005-07-2930
P407
P577
2005-09-27T00:00:00Z